MedPath

CHRISTENSEN MIKKEL

πŸ‡«πŸ‡·France
Ownership
-
Employees
-
Market Cap
-
Website

Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes

Not Applicable
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Other: Saline
Other: GLP-1
Other: GIP
First Posted Date
2017-06-22
Last Posted Date
2017-06-23
Lead Sponsor
Mikkel Christensen
Target Recruit Count
10
Registration Number
NCT03195257

Liraglutide in Spinal Fluid

Not Applicable
Completed
Conditions
Liraglutide Blood-brain Transfer
Interventions
Procedure: Lumbar puncture
First Posted Date
2014-04-04
Last Posted Date
2014-04-04
Lead Sponsor
Mikkel Christensen
Target Recruit Count
8
Registration Number
NCT02104037
Locations
πŸ‡©πŸ‡°

Diabetes Research Division, Department of Medicine, Hellerup, Denmark

GIP and GLP-1 in Type 1 Diabetes

Not Applicable
Completed
Conditions
Hypoglycemia
Interventions
Other: GIP
Other: GLP-1
Other: Saline
First Posted Date
2012-12-03
Last Posted Date
2015-07-13
Lead Sponsor
Mikkel Christensen
Target Recruit Count
10
Registration Number
NCT01739283
Locations
πŸ‡©πŸ‡°

Gentofte Hospital, Hellerup, Denmark

GIP Effects at Insulin Induced Hypoglycemia in Patients With Type 2 Diabetes

Early Phase 1
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Other: Glucose-dependent Insulinotropic polypeptide
Other: saline
First Posted Date
2011-08-11
Last Posted Date
2013-04-02
Lead Sponsor
Mikkel Christensen
Target Recruit Count
12
Registration Number
NCT01414556
Locations
πŸ‡©πŸ‡°

Gentofte Hospital, Hellerup, Denmark

Β© Copyright 2025. All Rights Reserved by MedPath